# US 2002/0120225 A1 · Ultrasound enhancement of percutaneous drug absorption

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0120225 A1
- Document ID: US20020120225A1
- Status: Published application
- Kind: A1
- Application number: 09/876,157
- Filed: 2001-06-08
- Published: 2002-08-29
- Earliest claimed: 1998-05-29
- Assignees: Light BioScience, LLC
- Inventors: David H. McDaniel
- Web page: https://patentgrep.com/patent/US20020120225A1

## CPC

- A61M 31/002: {Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time (artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50)}
- A61M 37/0092: {using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis}
- A61B 2017/00765: {Decreasing the barrier function of skin tissue by radiated energy, e.g. using ultrasound, using laser for skin perforation}
- A61M 2037/0007: {having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A system for enhancing and improving the transcutaneous or transdermal delivery of topical chemicals or drugs. A disposable container contains a substantially sterile unit dose of an active agent adapted for a single use in a medical treatment. The unit dose is formulated to enhance transport of the active agent through mammalian skin when the active agent is applied to the skin and the skin is exposed to light and/or ultrasound defined by at least one specific parameter.

## Claims

### Claim 1

A method for enhancing the transport of an active agent through mammalian skin, comprising:
exposing the skin to ultrasound, and
applying an active agent to the skin,
wherein the step of applying an active agent to the skin comprises injecting the active agent into the skin, and wherein the active agent comprises at least one of Vitamin C, Vitamin E, Vitamin A, Vitamin K, Vitamin F, Retin A (Tretinoin), Adapalene, Retinol, Hydroquinone, Kojic acid, a growth factor, echinacea, an antibiotic, an antifungal, an antiviral, a bleaching agent, an alpha hydroxy acid, a beta hydroxy acid, salicylic acid, antioxidant triad compound, a seaweed derivative, a salt water derivative, an antioxidant, a phytoanthocyanin, a phytonutrient, a botanical product, a herbaceous product, a hormone, an enzyme, a mineral, a genetically engineered substance, a cofactor, a catalyst, an antiaging substance, insulin, trace elements, minerals, Rogaine, a hair growth stimulating substance, a hair growth inhibiting substance, a dye, a natural or synthetic melanin, a metalloproteinase inhibitor, proline, hydroxyproline, an anesthetic substance.

### Claim 2

A method for enhancing the transport of an active agent through mammalian skin, wherein the skin comprises a stratum corneum, the method comprising:
exposing the skin to ultrasound,
applying an active agent to the skin, and
modifying at least portion of the stratum corneum substantially prior to the step of exposing the skin to ultrasound, wherein the step of modifying at least a portion of the stratum corneum comprises at least one of the steps of:
removing at least a follicular plug from the stratum corneum,
removing at least skin debris from the stratum corneum, and
removing at least a portion of the stratum corneum,
wherein the active agent comprises at least one of human fibroblasts, a preparation containing human fibroblasts, Vitamin C, Vitamin E, Vitamin A, Vitamin K, Vitamin F, Retin A (Tretinoin), Adapalene, Retinol, Hydroquinone, Kojic acid, a growth factor, echinacea, an antibiotic, an antifungal, an antiviral, a bleaching agent, an alpha hydroxy acid, a beta hydroxy acid, salicylic acid, antioxidant triad compound, a seaweed derivative, a salt water derivative, an antioxidant, a phytoanthocyanin, a phytonutrient, a botanical product, a herbaceous product, a hormone, an enzyme, a mineral, a genetically engineered substance, a cofactor, a catalyst, an antiaging substance, insulin, trace elements, minerals, Rogaine, a hair growth stimulating substance, a hair growth inhibiting substance, a dye, a natural or synthetic melanin, a metalloproteinase inhibitor, proline, hydroxyproline, an anesthetic substance.

### Claim 3

A method for enhancing the transport of an active agent through mammalian skin, wherein the skin comprises a stratum corneum, the method comprising:
exposing the skin to ultrasound,
applying an active agent to the skin, and
modifying at least portion of the stratum corneum substantially prior to the step of exposing the skin to ultrasound, wherein the step of modifying at least a portion of the stratum corneum comprises at least one of the steps of:
removing at least a follicular plug from the stratum corneum,
removing at least skin debris from the stratum corneum, and
removing at least a portion of the stratum corneum,
wherein the stratum corneum is characterized by a structure, a function, a thickness and a permeability and wherein the step of modifying at least a portion of the stratum corneum comprises at least one of the steps of stripping, removing, thinning and diminishing at least one of the structure, function, thickness and permeability of the stratum corneum by at least one of a mechanical, abrasive, photo acoustic, ablative, thermal, chemical, abrasive and enzymatic method.

### Claim 4

A method for enhancing the transport of an active agent through mammalian skin, wherein the skin comprises a stratum corneum, the method comprising:
exposing the skin to ultrasound,
applying an active agent to the skin, and
modifying at least portion of the stratum corneum substantially prior to the step of exposing the skin to ultrasound, wherein the step of modifying at least a portion of the stratum corneum comprises at least one of the steps of:
removing at least a follicular plug from the stratum corneum,
removing at least skin debris from the stratum corneum, and
removing at least a portion of the stratum corneum,
wherein the step of modifying at least a portion of the stratum corneum comprises at least one of the steps of solvent stripping, tape stripping, scrubbing, laser ablation, laser vaporization, chemical peeling, micro dermabrasion, and laser treatment using a high peak power, short pulse duration laser.

### Claim 5

A method for enhancing the transport of an active agent through mammalian skin, wherein the skin comprises a stratum comeum, the method comprising:
exposing the skin to ultrasound,
applying an active agent to the skin, and
modifying at least portion of the stratum corneum substantially prior to the step of exposing the skin to ultrasound, wherein the step of modifying at least a portion of the stratum corneum comprises at least one of the steps of:
removing at least a follicular plug from the stratum corneum,
removing at least skin debris from the stratum corneum, and
removing at least a portion of the stratum corneum,
wherein the step of modifying at least a portion of the stratum corneum comprises the step of applying an enzyme peel.

### Claim 6 (depends on 5)

The method of claim 5, wherein the enzyme peel is formulated to remove primarily dead stratum corneum cells.

### Claim 7

A method for enhancing the transport of an active agent through mammalian skin, comprising:
exposing the skin to ultrasound, and
applying an active agent to the skin,
wherein the step of applying an active agent to the skin comprises at least one of inserting, injecting, and placing fibroblasts into the skin associated with a collagen, a synthetic matrix or a bioengineered matrix.

### Claim 8 (depends on 7)

The method of claim 7, wherein the fibroblasts comprise at least one of fetal, autologous, donor, and genetically engineered fibroblasts.

### Claim 9 (depends on 7)

The method of claim 7, wherein the collagen comprises fetal collagen.

### Claim 10 (depends on 7)

The method of claim 7, comprising the step of exposing the skin to at least one of light, ultrasound, and a topical agent substantially subsequent to the step of at least one of inserting, injecting, and placing fibroblasts into the skin.

### Claim 11 (depends on 10)

The method of claim 10, wherein the topical agent comprises collagen.

### Claim 12

A method for enhancing the transport of an active agent through mammalian skin, wherein the skin comprises a stratum corneum, the method comprising:
exposing the skin to ultrasound,
applying an active agent to the skin, and
modifying at least portion of the stratum corneum substantially prior to the step of exposing the skin to ultrasound, wherein the step of modifying at least a portion of the stratum comeum comprises at least one of the steps of:
removing at least a follicular plug from the stratum corneum,
removing at least skin debris from the stratum corneum, and
removing at least a portion of the stratum corneum, and
at least one of inserting, injecting, and placing fibroblasts into the skin associated with a collagen, a synthetic matrix or a bioengineered matrix.

### Claim 13 (depends on 12)

The method of claim 12, wherein the fibroblasts comprise at least one of fetal, autologous, donor, and genetically engineered fibroblasts.

### Claim 14 (depends on 12)

The method of claim 12, wherein the collagen comprises fetal collagen.

### Claim 15 (depends on 12)

The method of claim 12, comprising the step of exposing the skin to at least one of light, ultrasound, and a topical agent substantially subsequent to the step of at least one of inserting, injecting, and placing fibroblasts into the skin.

### Claim 16 (depends on 15)

The method of claim 15, wherein the topical agent comprises collagen.

### Claim 17

A method for enhancing the transport of an active agent through mammalian skin, comprising:
exposing the skin to light,
exposing the skin to ultrasound, and
applying an active agent to the skin, wherein the step of applying an active agent to the skin comprises injecting the active agent into the skin.

### Claim 18 (depends on 17)

The method of claim 17, wherein the active agent comprises human fibroblasts.

### Claim 19 (depends on 17)

The method of claim 17, wherein the active agent comprises a preparation containing human fibroblasts.

### Claim 20

A method for enhancing the transport of an active agent through mammalian skin, wherein the skin comprises a stratum corneum, the method comprising:
exposing the skin to light,
exposing the skin to ultrasound,
applying an active agent to the skin, and
modifying at least portion of the stratum corneum substantially prior to at least one of the steps of exposing the skin to light and exposing the skin to ultrasound, wherein the step of modifying at least a portion of the stratum corneum comprises at least one of the steps of:
removing at least a follicular plug from the stratum corneum,
removing at least skin debris from the stratum corneum, and
removing at least a portion of the stratum corneum.

### Claim 21 (depends on 17)

The method of claim 17, wherein the active agent comprises at least one of Vitamin C, Vitamin E, Vitamin A, Vitamin K, Vitamin F, Retin A (Tretinoin), Adapalene, Retinol, Hydroquinone, Kojic acid, a growth factor, echinacea, an antibiotic, an antifungal, an antiviral, a bleaching agent, an alpha hydroxy acid, a beta hydroxy acid, salicylic acid, antioxidant triad compound, a seaweed derivative, a salt water derivative, an antioxidant, a phytoanthocyanin, a phytonutrient, a botanical product, a herbaceous product, a hormone, an enzyme, a mineral, a genetically engineered substance, a cofactor, a catalyst, an antiaging substance, insulin, trace elements, minerals, Rogaine, a hair growth stimulating substance, a hair growth inhibiting substance, a dye, a natural or synthetic melanin, a metalloproteinase inhibitor, proline, hydroxyproline, an anesthetic substance.

### Claim 22 (depends on 20)

The method of claim 20, wherein the active agent comprises at least one of human fibroblasts, a preparation containing human fibroblasts, Vitamin C, Vitamin E, Vitamin A, Vitamin K, Vitamin F, Retin A (Tretinoin), Adapalene, Retinol, Hydroquinone, Kojic acid, a growth factor, echinacea, an antibiotic, an antifungal, an antiviral, a bleaching agent, an alpha hydroxy acid, a beta hydroxy acid, salicylic acid, antioxidant triad compound, a seaweed derivative, a salt water derivative, an antioxidant, a phytoanthocyanin, a phytonutrient, a botanical product, a herbaceous product, a hormone, an enzyme, a mineral, a genetically engineered substance, a cofactor, a catalyst, an antiaging substance, insulin, trace elements, minerals, Rogaine, a hair growth stimulating substance, a hair growth inhibiting substance, a dye, a natural or synthetic melanin, a metalloproteinase inhibitor, proline, hydroxyproline, an anesthetic substance.

### Claim 23 (depends on 20)

The method of claim 20, wherein the stratum corneum is characterized by a structure, a function, a thickness and a permeability and wherein the step of modifying at least a portion of the stratum corneum comprises at least one of the steps of stripping, removing, thinning and diminishing at least one of the structure, function, thickness and permeability of the stratum corneum by at least one of a mechanical, abrasive, photo acoustic, ablative, thermal, chemical, abrasive and enzymatic method.

### Claim 24 (depends on 20)

The method of claim 20, wherein the step of modifying at least a portion of the stratum corneum comprises at least one of the steps of solvent stripping, tape stripping, scrubbing, laser ablation, laser vaporization, chemical peeling, micro dermabrasion, and laser treatment using a high peak power, short pulse duration laser.

### Claim 25 (depends on 20)

The method of claim 20, wherein the step of modifying at least a portion of the stratum corneum comprises the step of applying an enzyme peel.

### Claim 26 (depends on 25)

The method of claim 25, wherein the enzyme peel is formulated to remove primarily dead stratum corneum cells.

### Claim 27 (depends on 17)

The method of claim 17, comprising
at least one of inserting, injecting, and placing fibroblasts into the skin associated with a collagen, a synthetic matrix or a bioengineered matrix.

### Claim 28 (depends on 27)

The method of claim 27, wherein the fibroblasts comprise at least one of fetal, autologous, donor, and genetically engineered fibroblasts.

### Claim 29 (depends on 27)

The method of claim 27, wherein the collagen comprises fetal collagen.

### Claim 30 (depends on 27)

The method of claim 27, comprising the step of exposing the skin to at least one of light, ultrasound, and a topical agent substantially subsequent to the step of at least one of inserting, injecting, and placing fibroblasts into the skin.

### Claim 31 (depends on 30)

The method of claim 30, wherein the topical agent comprises collagen.

### Claim 32 (depends on 20)

The method of claim 20, comprising
at least one of inserting, injecting, and placing fibroblasts into the skin associated with a collagen, a synthetic matrix or a bioengineered matrix.

### Claim 33 (depends on 32)

The method of claim 32, wherein the fibroblasts comprise at least one of fetal, autologous, donor, and genetically engineered fibroblasts.

### Claim 34 (depends on 32)

The method of claim 32, wherein the collagen comprises fetal collagen.

### Claim 35 (depends on 32)

The method of claim 32, comprising the step of exposing the skin to at least one of light, ultrasound, and a topical agent substantially subsequent to the step of at least one of inserting, injecting, and placing fibroblasts into the skin.

### Claim 36 (depends on 35)

The method of claim 35, wherein the topical agent comprises collagen.

### Claim 37

A method for enhancing the transport of an active agent through mammalian skin, comprising:
exposing the skin to light, and
applying an active agent to the skin, wherein the step of applying an active agent to the skin comprises injecting the active agent into the skin.

### Claim 38 (depends on 37)

The method of claim 37, wherein the active agent comprises human fibroblasts.

### Claim 39 (depends on 37)

The method of claim 37, wherein the active agent comprises a preparation containing human fibroblasts.

### Claim 40

A method for enhancing the transport of an active agent through mammalian skin, wherein the skin comprises a stratum corneum, the method comprising:
exposing the skin to light,
applying an active agent to the skin, and
modifying at least portion of the stratum corneum substantially prior to the step of exposing the skin to light, wherein the step of modifying at least a portion of the stratum corneum comprises at least one of the steps of:
removing at least a follicular plug from the stratum corneum,
removing at least skin debris from the stratum comeum, and
removing at least a portion of the stratum corneum.

### Claim 41 (depends on 37)

The method of claim 37, wherein the active agent comprises at least one of Vitamin C, Vitamin E, Vitamin A, Vitamin K, Vitamin F, Retin A (Tretinoin), Adapalene, Retinol, Hydroquinone, Kojic acid, a growth factor, echinacea, an antibiotic, an antifungal, an antiviral, a bleaching agent, an alpha hydroxy acid, a beta hydroxy acid, salicylic acid, antioxidant triad compound, a seaweed derivative, a salt water derivative, an antioxidant, a phytoanthocyanin, a phytonutrient, a botanical product, a herbaceous product, a hormone, an enzyme, a mineral, a genetically engineered substance, a cofactor, a catalyst, an antiaging substance, insulin, trace elements, minerals, Rogaine, a hair growth stimulating substance, a hair growth inhibiting substance, a dye, a natural or synthetic melanin, a metalloproteinase inhibitor, proline, hydroxyproline, an anesthetic substance.

### Claim 42 (depends on 40)

The method of claim 40, wherein the active agent comprises at least one of human fibroblasts, a preparation containing human fibroblasts, Vitamin C, Vitamin E, Vitamin A, Vitamin K, Vitamin F, Retin A (Tretinoin), Adapalene, Retinol, Hydroquinone, Kojic acid, a growth factor, echinacea, an antibiotic, an antifungal, an antiviral, a bleaching agent, an alpha hydroxy acid, a beta hydroxy acid, salicylic acid, antioxidant triad compound, a seaweed derivative, a salt water derivative, an antioxidant, a phytoanthocyanin, a phytonutrient, a botanical product, a herbaceous product, a hormone, an enzyme, a mineral, a genetically engineered substance, a cofactor, a catalyst, an antiaging substance, insulin, trace elements, minerals, Rogaine, a hair growth stimulating substance, a hair growth inhibiting substance, a dye, a natural or synthetic melanin, a metalloproteinase inhibitor, proline, hydroxyproline, an anesthetic substance.

### Claim 43 (depends on 40)

The method of claim 40, wherein the stratum corneum is characterized by a structure, a function, a thickness and a permeability and wherein the step of modifying at least a portion of the stratum corneum comprises at least one of the steps of stripping, removing, thinning and diminishing at least one of the structure, function, thickness and permeability of the stratum corneum by at least one of a mechanical, abrasive, photo acoustic, ablative, thermal, chemical, abrasive and enzymatic method.

### Claim 44 (depends on 40)

The method of claim 40, wherein the step of modifying at least a portion of the stratum corneum comprises at least one of the steps of solvent stripping, tape stripping, scrubbing, laser ablation, laser vaporization, chemical peeling, micro dermabrasion, and laser treatment using a high peak power, short pulse duration laser.

### Claim 45 (depends on 40)

The method of claim 40, wherein the step of modifying at least a portion of the stratum comeum comprises the step of applying an enzyme peel.

### Claim 46 (depends on 45)

The method of claim 45, wherein the enzyme peel is formulated to remove primarily dead stratum corneum cells.

### Claim 47 (depends on 37)

The method of claim 37, comprising
at least one of inserting, injecting, and placing fibroblasts into the skin associated with a collagen, a synthetic matrix or a bioengineered matrix.

### Claim 48 (depends on 47)

The method of claim 47, wherein the fibroblasts comprise at least one of fetal, autologous, donor, and genetically engineered fibroblasts.

### Claim 49 (depends on 47)

The method of claim 47, wherein the collagen comprises fetal collagen.

### Claim 50 (depends on 47)

The method of claim 47, comprising the step of exposing the skin to at least one of light, ultrasound, and a topical agent substantially subsequent to the step of at least one of inserting, injecting, and placing fibroblasts into the skin.

### Claim 51 (depends on 50)

The method of claim 50, wherein the topical agent comprises collagen.

### Claim 52 (depends on 40)

The method of claim 40, comprising
at least one of inserting, injecting, and placing fibroblasts into the skin associated with a collagen, a synthetic matrix or a bioengineered matrix.

### Claim 53 (depends on 52)

The method of claim 52, wherein the fibroblasts comprise at least one of fetal, autologous, donor, and genetically engineered fibroblasts.

### Claim 54 (depends on 52)

The method of claim 52, wherein the collagen comprises fetal collagen.

### Claim 55 (depends on 52)

The method of claim 52, comprising the step of exposing the skin to at least one of light, ultrasound, and a topical agent substantially subsequent to the step of at least one of inserting, injecting, and placing fibroblasts into the skin.

### Claim 56 (depends on 55)

The method of claim 55, wherein the topical agent comprises collagen.
